NEWARK, Del.--(BUSINESS WIRE)--Sept. 7, 2006--Strategic Diagnostics Inc. (NASDAQ:SDIX) today announced that it has signed a new agreement to supply bio-reagents to a large manufacturer of in-vitro diagnostics. The initial term of the agreement is five years. Starting revenues are estimated at $1 million per year and are anticipated to more than double over the term of the agreement. Strategic Diagnostics will begin shipping bio-reagents to the customer in the fourth quarter of 2006.
